Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2018. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3621127015 | Ceftaroline fosamil acetic acid solvate monohydrate (substance) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 3621128013 | Ceftaroline fosamil acetic acid solvate monohydrate | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Ceftaroline fosamil acetic acid solvate monohydrate | Is a | Ceftaroline | false | Inferred relationship | Existential restriction modifier | ||
| Ceftaroline fosamil acetic acid solvate monohydrate | Has disposition | Antibacterial | true | Inferred relationship | Existential restriction modifier | ||
| Ceftaroline fosamil acetic acid solvate monohydrate | Is a | Substance with cephalosporin structure and antibacterial mechanism of action | false | Inferred relationship | Existential restriction modifier | ||
| Ceftaroline fosamil acetic acid solvate monohydrate | Is modification of | Ceftaroline | false | Inferred relationship | Existential restriction modifier | ||
| Ceftaroline fosamil acetic acid solvate monohydrate | Is a | Cephalosporin | true | Inferred relationship | Existential restriction modifier | ||
| Ceftaroline fosamil acetic acid solvate monohydrate | Is modification of | Ceftaroline fosamil acetic acid solvate | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Ceftaroline fosamil 600mg powder for solution for infusion vials | Has specific active ingredient | True | Ceftaroline fosamil acetic acid solvate monohydrate | Inferred relationship | Existential restriction modifier | |
| Ceftaroline fosamil 600mg powder for solution for infusion vials 10 vial | Has specific active ingredient | True | Ceftaroline fosamil acetic acid solvate monohydrate | Inferred relationship | Existential restriction modifier | |
| Zinforo 600mg powder for concentrate for solution for infusion vials (AstraZeneca UK Ltd) 10 vial | Has specific active ingredient | True | Ceftaroline fosamil acetic acid solvate monohydrate | Inferred relationship | Existential restriction modifier | |
| Zinforo 600mg powder for concentrate for solution for infusion vials (AstraZeneca UK Ltd) | Has specific active ingredient | True | Ceftaroline fosamil acetic acid solvate monohydrate | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR